Combined treatment with oral kanamycin and parenteral antibiotics for a case of persistent bacteremia and intestinal carriage with Campylobacter coli

Internal Medicine

Volumn 47, Issue 14, 2008, Pages 1363-1366

  Okada, Haruka ^a   Kitazawa, Takatoshi ^a   Harada, Sohei ^a   Itoyama, Satoru ^a   Hatakeyama, Shuji ^a   Ota, Yasuo ^a,b   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Campylobacter coli; Oral kamamycin; X linked agammaglobulinemia

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; CEFCAPENE PIVOXIL; CEFOTAXIME; CEFPIROME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; IMMUNOGLOBULIN; KANAMYCIN; MEROPENEM; MINOCYCLINE; SULTAMICILLIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIUM CARRIER; BLOOD CULTURE; CAMPYLOBACTER COLI; CASE REPORT; CELLULITIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERADICATION THERAPY; FEVER; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE INFECTION; INTESTINE MUCOSA; KIDNEY TUBULE DAMAGE; LABORATORY TEST; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; RECURRENT INFECTION; SYSTOLIC HEART MURMUR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT DURATION; X LINKED AGAMMAGLOBULINEMIA; AGAMMAGLOBULINEMIA; DRUG COMBINATION; DYSENTERY; ENDOCARDITIS; GRAM NEGATIVE INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGICAL EXAMINATION; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; AGAMMAGLOBULINEMIA; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER COLI; CAMPYLOBACTER INFECTIONS; DRUG THERAPY, COMBINATION; DYSENTERY; ENDOCARDITIS; HUMANS; INFUSIONS, INTRAVENOUS; KANAMYCIN; MALE; MICROBIAL SENSITIVITY TESTS; OSTEOMYELITIS;

EID: 53049105565     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1161     Document Type: Article

References (22)

1. Pigrau C, Bartolome R, Almirante B, Planes AM, Gavalda J, Pahissa A. Bacteremia due to Campylobacter species, clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis 25: 1414-1420, 1997.
2. Blaster MG, Bennett JE, Dolin R. Campylobacter jejuni and related species. In: Mandell, Douglas and Bennette's Principles and Practice of Infectious Diseases. 6th ed. Mandell GL, Douglas RG, Bennett JE, Eds. Elsevier/Churchill Livingstone, New York, 2005: 2276-2285.
3. Peterson MC. Clinical aspects of Campylobacter jejuni infections in adults. West J Med 161: 148-152, 1994.
4. Akiba T, Akiba K, Suto N, Kumagai K, Sakamoto M, Yazaki N. Campylobacter coli bacteremia in an 11-year-old boy. Pediatr Int 44: 543-544, 2002.
5. Ladron de, Guevara C, Gonzalez J, Pena P. Bacteraemia caused by Campylobacter spp. J Clin Pathol 47: 174-175, 1994.
6. Fitzgerald C, Dolin R. Campylobacter and Arcobacter. In: Manual of Clinical Microbiology. 9th ed. Murray PR, Baron EJ, Jorgensen JH, et al, Eds. American Society for Microbiology, Washington, DC, 2007: 933-946.
7. Gonzalez I, Grant KA, Richardson PT, Park SF, Collins MD. Specific identification of the enteropathogens Campylobacter jejuni and Campylobacter coli by using a PCR test based on the ceuE gene encoding a putative virulence determinant. J Clin Microbiol 35: 759-763, 1997.
8. Black RE, Perlman D, Clements ML. Human volunteer studies with Campylobacter jejuni. In: Campylobacter jejuni. Current Status and Future Trends. Nachmkin I, Blaser MJ, Topmpkins LS, Eds. American Society for Microbiology, Washington DC, 1992: 207-215.
9. Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ. Experimental Campylobacter jejuni infection in humans. J Infect Dis 157: 472-479, 1988.
10. Johnson RJ, Nolan C, Wang SP, Shelton WR, Blaser MJ. Persistent Campylobacter jejuni infection in an immunocompromised patient. Ann Intern Med 100: 832-834, 1984.
11. Perlman DM, Ampel NM, Schifman RB, et al. Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV). Ann Intern Med 1108: 540-546, 1988.
12. Arai A, Kitano A, Sawabe E, Kanegane H, Miyawaki T, Miura O. Relapsing Campylobacter coli bacteremia with reactive arthritis in a patient with X-linked agammaglobulinemia. Intern Med 46: 605-609, 2007.
13. van der Meer JW, Mouton RP, Daha MR, Schuurman RK. Campylobacter jejuni bacteraemia as a cause of recurrent fever in a patient with hypogammaglobulinaemia. J Infect 12: 235-239, 1986.
14. Spelman DW, Davidson N, Buckmaster ND, Spicer WJ, Ryan P. Campylobacter bacteraemia: a report of 10 cases. Med J Aust 145: 503-505, 1986.
15. Chusid MJ, Coleman CM, Dunne WM. Chronic asymptomatic Campylobacter bacteremia in a boy with X-linked hypogam-maglobulinemia. Pediatr Infect Dis 16: 943-944, 1987.
16. Autenrieth IB, Schuster V, Ewald J, Harmsen D, Kreth HW. An unusual case of refractory Campylobacter jejuni infection in a patient with X-linked agammaglobulinemia: successful combined therapy with maternal plasma and ciprofloxacin. Clin Infect Dis 23: 526-531, 1996.
17. Rafi A, Matz J. An unusual case of Campylobacter jejuni pericarditis in a patient with X-linked agammaglobulinemia. Ann Allergy Asthma Immunol 89: 362-367, 2002.
18. Tokuda K, Nishi J, Miyanohara H, et al. Relapsing cellulitis associated with Campylobacter coli bacteremia in an agammaglobulinemic patient. Pediatr Infect Dis J 23: 577-579, 2004.
19. Van der Hilst JC, Smits BW, van der Meer JW. Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution. Neth J Med 60: 140-147, 2002.
20. Freeman AF, Holland SM. Persistent bacterial infections and primary immune disorders. Curr Opin Microbiol 10: 70-75, 2007.
21. Wooldridge KG, Ketley JM. Campylobacter-host cell interactions. Trends Microbiol 5: 96-102, 1997.
22. Molina J, Casin I, Hausfater P, et al. Campylobacter infections in HIV-infected patients: clinical and bacteriological features. Aids 9: 881-885, 1995.